Abstract:Background: Endogenous insulin supplementation is essential for individuals with type 1 diabetes (T1D). However, current treatments, including pancreas transplantation, insulin injections, and oral medications, have significant limitations. The development of engineered cells that can secrete endogenous insulin offers a promising new therapeutic strategy for type 1 diabetes (T1D). This approach could potentially circumvent autoimmune responses associated with the transplantation of differentiated β-cells or systemic delivery of viral vectors. Methods: We utilized CRISPR/Cas9 gene editing coupled with homology-directed repair (HDR) to precisely integrate a promoter-free EMCVIRES-insulin cassette into the 3' untranslated region (UTR) of the GAPDH gene in human HEK-293T cells. Subsequently quantified insulin expression levels in these engineered cells, the viability and functionality of the engineered cells when seeded on different cell vectors (GelMA and Cytopore I) were also assessed. Finally, we investigated the therapeutic potential of EMCVIRES-based insulin secretion circuits in reversing Hyperglycaemia in T1D mice. Result: Our results demonstrate that HDR-mediated gene editing successfully integrated the IRES-insulin loop into the genome of HEK-293T cells, a non-endocrine cell line, enabling the expression of human-derived insulin. Furthermore, Cytopore I microcarriers facilitated cell attachment and proliferation during in vitro culture and enhanced cell survival post-transplantation. Transplantation of these cell-laden microcarriers into mice led to the development of a stable, fat-encapsulated structure. This structure exhibited the expression of the platelet-endothelial cell adhesion molecule CD31, and no significant immune rejection was observed throughout the experiment. Diabetic mice that received the cell carriers reversed hyperglycemia, and blood glucose fluctuations under simulated feeding stimuli were very similar to those of healthy mice. Conclusion: In summary, our study demonstrates that Cytopore I microcarriers are biocompatible and promote long-term cell survival in vivo. The promoter-free EMCVIRES-insulin loop enables non-endocrine cells to secrete mature insulin, leading to a rapid reduction in glucose levels. We have presented a novel promoter-free genetic engineering strategy for insulin secretion and proposed an efficient cell transplantation method. Our findings suggest the potential to expand the range of cell sources available for the treatment of diabetes, offering new avenues for therapeutic interventions.

Insulin Expression in Livers of Diabetic Mice Mediated by Hydrodynamics-Based Administration

Direct Transfer of A20 Gene into Pancreas Protected Mice from Streptozotocin-Induced Diabetes

Ultrasound-Targeted Microbubble Destruction Mediates Gene Transfection for Beta-Cell Regeneration and Glucose Regulation.

Direct Reprogramming of Hepatocytes into Insulin-Producing Cells for Anti-Diabetic Treatment by Ultrasound-Targeted Microbubble Destruction Enhanced Hydrodynamic Gene Delivery

In Vivo Targeted Delivery of ANGPTL8 Gene for Beta Cell Regeneration in Rats

Intramuscular Injection of Interleukin-10 Plasmid DNA Prevented Autoimmune Diabetes in Mice

Successful β cells islet regeneration in streptozotocin-induced diabetic baboons using ultrasound-targeted microbubble gene therapy with cyclinD2/CDK4/GLP1.

In vivo direct reprogramming of liver cells to insulin producing cells by virus-free overexpression of defined factors.

Intramuscular Injection of Naked Plasmid DNA Encoding Human Preproinsulin Gene in Streptozotocin-Diabetes Mice Results in a Significant Reduction of Blood Glucose Level.

Effect of Hepatic Insulin Expression on Lipid Metabolism in Diabetic Mice

Naked Plasmid Mediated Expression and Therapeutical Effect of Mutant Human Proinsulin Gene in Diabetic Mice

Prolonged Control of Insulin-Dependent Diabetes Via Intramuscular Expression of Plasmid-Encoded Single-Strand Insulin Analogue

Glucose-regulated Insulin Production in the Liver Improves Glycemic Control in Type 1 Diabetic Mice.

The Effect of Human Insulin Gene Modified Fibroblasts in Diabetic Rats

High levels of gene expression in the hepatocytes of adult mice, neonatal mice and tree shrews via retro-orbital sinus hydrodynamic injections of naked plasmid DNA

Efficient, Glucose Responsive, and Cell-Specific Transgene Expression in Pancreatic Islets.

Insulin gene transfer enhances the function of human islet grafts

Gene Therapy for Type 1 Diabetes Mellitus in Rats by Gastrointestinal Administration of Chitosan Nanoparticles Containing Human Insulin Gene

Adeno-associated Virus-Mediated Pancreatic and Duodenal Homeobox Gene 1 Delivery Induced Insulin-Producing Cells in Livers of Diabetic Rats

[Expression of Human Insulin Gene in Vitro and in Vivo].

Engineered IRES-mediated promoter-free insulin-producing cells reverse hyperglycemia